JP2018520124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520124A5 JP2018520124A5 JP2017563973A JP2017563973A JP2018520124A5 JP 2018520124 A5 JP2018520124 A5 JP 2018520124A5 JP 2017563973 A JP2017563973 A JP 2017563973A JP 2017563973 A JP2017563973 A JP 2017563973A JP 2018520124 A5 JP2018520124 A5 JP 2018520124A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- heterocycloalkyl
- alkylene
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562185203P | 2015-06-26 | 2015-06-26 | |
| US62/185,203 | 2015-06-26 | ||
| PCT/US2016/039270 WO2016210275A1 (en) | 2015-06-26 | 2016-06-24 | Treatment of nut midline carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018520124A JP2018520124A (ja) | 2018-07-26 |
| JP2018520124A5 true JP2018520124A5 (2) | 2019-07-25 |
Family
ID=56409188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017563973A Pending JP2018520124A (ja) | 2015-06-26 | 2016-06-24 | Ｎｕｔ正中線癌の治療 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20180193350A1 (2) |
| EP (1) | EP3314005A1 (2) |
| JP (1) | JP2018520124A (2) |
| KR (1) | KR20180035785A (2) |
| CN (1) | CN107787227A (2) |
| AR (1) | AR105124A1 (2) |
| AU (1) | AU2016283020A1 (2) |
| BR (1) | BR112017028178A2 (2) |
| CA (1) | CA2989313A1 (2) |
| HK (1) | HK1252062A1 (2) |
| IL (1) | IL256186A (2) |
| MA (1) | MA42249A (2) |
| MX (1) | MX2017016337A (2) |
| WO (1) | WO2016210275A1 (2) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX354217B (es) | 2010-05-14 | 2018-02-19 | Dana Farber Cancer Inst Inc | Composiciones y metodos para el tratamiento de leucemia. |
| PL2902030T3 (pl) | 2010-05-14 | 2017-07-31 | Dana-Farber Cancer Institute, Inc. | Związki tienotriazolodiazepinowe do leczenia nowotworu |
| RU2016122654A (ru) | 2013-11-08 | 2017-12-14 | Дана-Фарбер Кэнсер Инститьют, Инк. | Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка |
| JP2017506666A (ja) | 2014-02-28 | 2017-03-09 | テンシャ セラピューティクス，インコーポレイテッド | 高インスリン血症に関連した症状の処置 |
| KR20170068597A (ko) | 2014-10-27 | 2017-06-19 | 텐샤 세러퓨틱스 인코포레이티드 | 브로모도메인 저해제 |
| EP4629984A1 (en) * | 2022-12-06 | 2025-10-15 | BioVentures, LLC | Development of potent dual hdac/brd4 inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| KR101600634B1 (ko) | 2007-12-28 | 2016-03-07 | 미쓰비시 타나베 파마 코퍼레이션 | 항암제 |
| GB0919431D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| EP3050885B1 (en) | 2009-11-05 | 2017-10-18 | GlaxoSmithKline LLC | Benzodiazepine bromodomain inhibitor |
| GB0919432D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Use |
| AU2010314395B2 (en) | 2009-11-05 | 2015-04-09 | Glaxosmithkline Llc | Benzodiazepine bromodomain inhibitor |
| GB0919423D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| GB0919426D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| GB0919434D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| JP5715241B2 (ja) * | 2010-05-14 | 2015-05-07 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
| PL2902030T3 (pl) * | 2010-05-14 | 2017-07-31 | Dana-Farber Cancer Institute, Inc. | Związki tienotriazolodiazepinowe do leczenia nowotworu |
| JP5844358B2 (ja) | 2010-06-22 | 2016-01-13 | グラクソスミスクライン エルエルシー | ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤 |
| WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| US9422292B2 (en) | 2011-05-04 | 2016-08-23 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2012174487A2 (en) | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| JP2017506666A (ja) | 2014-02-28 | 2017-03-09 | テンシャ セラピューティクス，インコーポレイテッド | 高インスリン血症に関連した症状の処置 |
-
2016
- 2016-06-24 US US15/739,905 patent/US20180193350A1/en not_active Abandoned
- 2016-06-24 WO PCT/US2016/039270 patent/WO2016210275A1/en not_active Ceased
- 2016-06-24 JP JP2017563973A patent/JP2018520124A/ja active Pending
- 2016-06-24 AU AU2016283020A patent/AU2016283020A1/en not_active Abandoned
- 2016-06-24 HK HK18111394.9A patent/HK1252062A1/zh unknown
- 2016-06-24 MX MX2017016337A patent/MX2017016337A/es unknown
- 2016-06-24 CA CA2989313A patent/CA2989313A1/en not_active Abandoned
- 2016-06-24 EP EP16738292.8A patent/EP3314005A1/en not_active Withdrawn
- 2016-06-24 BR BR112017028178-3A patent/BR112017028178A2/en not_active Application Discontinuation
- 2016-06-24 AR ARP160101908A patent/AR105124A1/es unknown
- 2016-06-24 CN CN201680036201.4A patent/CN107787227A/zh active Pending
- 2016-06-24 MA MA042249A patent/MA42249A/fr unknown
- 2016-06-24 KR KR1020187000569A patent/KR20180035785A/ko not_active Withdrawn
-
2017
- 2017-12-07 IL IL256186A patent/IL256186A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520124A5 (2) | ||
| JP2017515856A5 (2) | ||
| JP2017121233A5 (2) | ||
| JP2019522055A5 (2) | ||
| JP2015532295A5 (2) | ||
| JP2019524883A5 (2) | ||
| JP2017521387A5 (2) | ||
| RU2016147742A (ru) | Дейтрированные гетероциклические соединения и их применение в качестве средств визуализации | |
| RU2019100164A (ru) | Гетероциклическое соединение, используемое как ингибитор fgfr | |
| JP2017530984A5 (2) | ||
| JP2017531673A5 (2) | ||
| JP2019537570A5 (2) | ||
| JP2016509047A5 (2) | ||
| JP2016513130A5 (2) | ||
| JP2009528271A5 (2) | ||
| JP2017528498A5 (2) | ||
| JP2011517683A5 (2) | ||
| JP2017537080A5 (2) | ||
| JP2019505529A5 (2) | ||
| JP2016503797A5 (2) | ||
| JP2013521233A5 (2) | ||
| JP2019516739A5 (2) | ||
| JP2016510326A5 (2) | ||
| JP2014513065A5 (2) | ||
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения |